Digital Dermatitis (Strawberry Foot Rot, Treponema-Associated Foot Dermatitis)

Digital dermatitis (DD) is a contagious, polymicrobial, superficial inflammatory disease of the digital and interdigital skin of cattle, primarily affecting the plantar aspect of the hind feet, particularly the skin adjacent to the heel bulbs. It is characterized by circumscribed, painful, erosive or proliferative lesions that often resemble a strawberry due to their red, granular appearance. DD is a major cause of lameness in dairy cattle worldwide, with significant economic impact due to reduced milk production, impaired fertility, increased culling, and treatment costs. The disease is considered a multifactorial condition involving treponeme bacteria, environmental hygiene, and host factors. It is most prevalent in intensive dairy systems, especially in housed cattle with poor hoof hygiene, and can also affect beef cattle and youngstock. The condition is distinct from other foot diseases such as foot rot (interdigital phlegmon) and sole ulcers, and requires specific diagnostic and therapeutic approaches.

Digital dermatitis is primarily caused by a complex of anaerobic spirochetes of the genus Treponema, including Treponema medium, Treponema phagedenis, and Treponema pedis. These bacteria are highly fastidious, motile, and are found in high numbers within the superficial layers of the lesion. They are often present in polymicrobial biofilms with other bacteria such as Fusobacterium necrophorum, Dichelobacter nodosus, and various Gram-positive cocci. The treponemes are believed to be the primary pathogens, as they are consistently identified in lesions and are associated with the characteristic epidermal hyperplasia and dermal inflammation. The exact pathogenic mechanism is not fully understood, but treponemes invade the epidermis and induce a host inflammatory response, leading to the formation of proliferative or erosive lesions. Environmental factors such as slurry, moisture, and poor hygiene facilitate bacterial survival and transmission. The disease is not systemic, and bacteremia is rare. The infectious nature is supported by the high prevalence in herds with poor biosecurity and the response to topical antimicrobials.

Digital dermatitis is a global disease, with prevalence rates in dairy herds ranging from 5% to 30% or higher, and some herds experiencing over 50% prevalence. It is more common in housed cattle, especially in free-stall systems with concrete flooring and inadequate manure removal. The disease affects all ages, but is most frequently diagnosed in first-lactation heifers and young cows, likely due to their introduction into contaminated environments. Holstein-Friesian and other high-yielding dairy breeds are more commonly affected, but beef cattle and calves can also develop DD. The condition is more prevalent in temperate climates with high rainfall and humidity, and during winter months when cattle are housed. Morbidity can be high, with up to 20-30% of cows affected in an outbreak, while mortality is negligible. Economic losses arise from reduced milk yield (estimated at 1-2 kg/day per affected cow), increased culling, treatment costs, and impaired reproductive performance. The disease is a major welfare concern due to pain and lameness.

The pathophysiology of digital dermatitis involves a complex interplay between bacterial invasion, host immune response, and environmental factors. The primary pathogens, Treponema spp., colonize the skin surface, particularly in areas with high moisture and organic matter. They penetrate the epidermis through microabrasions or intercellular spaces, leading to epidermal hyperplasia and dermal inflammation. The bacteria produce enzymes such as proteases and collagenases that degrade tissue components, facilitating deeper invasion. The host response includes infiltration of neutrophils, macrophages, and lymphocytes, resulting in the characteristic red, granulating appearance. Chronic lesions may become proliferative with hyperkeratosis and papillomatosis. The pain associated with DD is due to the exposure of dermal nerve endings and the release of inflammatory mediators such as prostaglandins and cytokines. The disease is localized to the skin and does not typically involve deeper structures like the corium or bone, unless secondary infections occur. The exact role of other bacteria in the biofilm is not fully defined, but they may contribute to the microenvironment and enhance treponeme survival.

Several intrinsic and extrinsic factors predispose cattle to digital dermatitis. Intrinsic factors include age (young cattle are more susceptible), breed (dairy breeds, especially Holsteins, are overrepresented), and immune status (periparturient immunosuppression increases susceptibility). High milk production is associated with increased risk, possibly due to metabolic stress and prolonged standing. Parity is a risk factor, with first-lactation heifers being particularly vulnerable. Extrinsic factors are primarily related to environmental hygiene: wet, dirty, and poorly maintained flooring, inadequate manure removal, and high stocking density. Foot bathing practices, if infrequent or improperly used, can also contribute. Nutritional factors, such as excessive dietary protein or energy, may indirectly affect hoof health and immune function. Lack of biosecurity, such as introduction of new animals without quarantine, can introduce the infection into a herd. Additionally, concurrent foot diseases like sole ulcers or white line disease can increase the risk of DD due to altered gait and increased exposure.

Clinical signs of digital dermatitis range from subclinical lesions to severe lameness. The hallmark is the presence of circumscribed, painful lesions on the skin of the heel bulbs, typically on the plantar aspect of the hind feet, but can also occur on the front feet or interdigital space. Lesions are often classified using the M-stage scoring system: M0 (normal skin), M1 (small active lesion <2 cm), M2 (classic active ulcerative or proliferative lesion, often strawberry-like), M3 (healing lesion covered by scab), M4 (chronic proliferative lesion with hyperkeratosis), and M4.1 (chronic lesion with active M1 areas). Active lesions (M2) are red, granular, and bleed easily, with a characteristic foul odor. They are extremely painful, leading to lameness, which is often worse on concrete surfaces. Cows may exhibit weight shifting, increased lying time, and reduced feed intake. In severe cases, swelling of the distal limb may occur, but systemic signs such as fever are rare. Chronic lesions (M4) are less painful but can become infected secondarily. The disease can also affect the interdigital space, causing interdigital dermatitis, which may be confused with foot rot.

Differential diagnoses for digital dermatitis include: 1) Foot rot (interdigital phlegmon): caused by Fusobacterium necrophorum and Bacteroides melaninogenicus, characterized by severe swelling of the interdigital space, deep tissue necrosis, and a characteristic foul odor; DD lesions are superficial and not associated with deep swelling. 2) Sole ulcer (pododermatitis circumscripta): a lesion on the sole at the typical site (sole ulcer zone), often associated with laminitis and corium damage; DD is on the skin, not the sole. 3) White line disease: separation of the white line with ascending infection, leading to abscess formation; DD does not involve the hoof wall. 4) Interdigital dermatitis (non-treponemal): a superficial dermatitis of the interdigital skin, often associated with poor hygiene, but not caused by Treponema; may be a precursor to foot rot. 5) Heel horn erosion: a non-infectious condition characterized by pitting and erosion of the heel horn, often associated with slurry; DD lesions are on the skin, not the horn. 6) Laminitis: a systemic condition causing claw horn lesions, lameness, and hoof deformities; DD is a localized skin infection. 7) Trauma or foreign body penetration: can cause localized swelling and lameness, but lesions are not typically on the heel skin. 8) Papillomatous digital dermatitis (same as DD) is a synonym, but other papillomas (viral warts) may be considered, though they are less painful and have a different appearance.

The diagnostic algorithm for digital dermatitis begins with a thorough herd history and locomotion scoring to identify affected cows. Individual cows with lameness should be examined in a chute or hoof trimming chute. The feet are cleaned and examined visually, with particular attention to the plantar aspect of the heel bulbs. The presence of characteristic lesions (M2 or M4) is usually sufficient for diagnosis. If the diagnosis is uncertain, a biopsy of the lesion can be taken for histopathology and PCR for Treponema spp. However, biopsy is rarely needed in clinical practice. Differential diagnoses should be ruled out based on lesion location and appearance. In herd-level investigations, the prevalence of DD can be assessed using the M-stage scoring system during routine hoof trimming. Environmental risk factors should be evaluated, including hygiene, flooring, and foot bathing practices. Laboratory tests are not routinely performed, but if secondary infection is suspected, bacterial culture or sensitivity may be indicated. The diagnosis is primarily clinical, and response to topical treatment can confirm the diagnosis.

Laboratory findings are not typically required for the diagnosis of digital dermatitis, as the condition is diagnosed based on clinical signs. However, if laboratory tests are performed, they may include: 1) Histopathology of a biopsy: shows epidermal hyperplasia, hyperkeratosis, parakeratosis, and infiltration of neutrophils and lymphocytes in the dermis. Spirochetes can be visualized with silver stains (e.g., Warthin-Starry) or immunohistochemistry. 2) PCR for Treponema spp.: can detect and identify specific treponeme species in lesion samples. 3) Bacterial culture: is difficult due to the fastidious nature of treponemes, but other bacteria such as Fusobacterium necrophorum may be cultured. 4) Blood work: is usually unremarkable, with no significant changes in CBC or serum biochemistry. If there is severe lameness, there may be mild elevations in acute phase proteins (e.g., haptoglobin), but this is non-specific. 5) Milk production and somatic cell count (SCC) are not directly affected by DD, but may be indirectly impacted due to stress and reduced feed intake.

Imaging is not routinely used for the diagnosis of digital dermatitis. However, in cases where deep infection or osteomyelitis is suspected, radiography may be performed to rule out bone involvement. Radiographs of the digit may show soft tissue swelling, but no bony changes are expected in uncomplicated DD. Ultrasonography is not commonly used, but could be used to assess soft tissue involvement or abscess formation. In research settings, advanced imaging such as MRI or CT may be used to characterize lesions, but these are not practical in clinical practice. Therefore, imaging is of limited value in the diagnosis of DD, and the diagnosis is primarily based on visual inspection.

Cytology and histopathology are useful for confirming the diagnosis of digital dermatitis, especially in atypical cases. Cytology of lesion scrapings or impression smears may reveal spirochetes with dark-field microscopy or special stains, but this is not commonly performed. Histopathology of a biopsy is more definitive. The epidermis shows marked hyperplasia with elongated rete pegs, hyperkeratosis, and parakeratosis. The dermis has a dense inflammatory infiltrate consisting of neutrophils, lymphocytes, plasma cells, and macrophages. Spirochetes are often visible in the superficial epidermis and dermal papillae with silver stains. In chronic lesions, there may be fibrosis and papillomatosis. The histopathological features are characteristic and can differentiate DD from other skin conditions such as viral papillomas or trauma. Biopsy is not routinely recommended but can be useful in herd outbreaks where the diagnosis is uncertain.

Treatment of digital dermatitis involves both individual cow therapy and herd-level control measures. For individual cows, the primary treatment is topical application of antimicrobial agents to the affected area. The most common topical treatments include oxytetracycline spray or solution, lincomycin, or a combination of tetracycline and gentian violet. The lesion should be cleaned and dried before application. Topical treatment is often applied daily for 3-5 days, or as a single application in some cases. Systemic antibiotics are not generally recommended for uncomplicated DD, but may be used in severe cases with secondary infection. Non-steroidal anti-inflammatory drugs (NSAIDs) such as flunixin meglumine or ketoprofen can be administered to relieve pain and inflammation. In severe cases, surgical debridement of the lesion may be necessary, but this is rarely required. Herd-level control includes foot bathing with formalin or copper sulfate solutions, improving hygiene, and reducing stocking density. Foot baths should be used regularly, especially in high-risk periods. Culling of chronically affected cows may be considered in severe cases. The prognosis for individual cows is good with prompt treatment, but recurrence is common.

The prognosis for digital dermatitis is generally good with appropriate treatment. Most active lesions (M2) respond to topical therapy within a few days, and lameness resolves. However, recurrence is common, especially if environmental risk factors are not addressed. Chronic lesions (M4) may persist and become less responsive to treatment. The long-term prognosis for milk production and fertility is generally favorable if the disease is managed effectively. However, severe or recurrent cases can lead to culling. Negative prognostic indicators include chronic lesions that do not respond to treatment, deep secondary infections, and high herd prevalence. Early detection and treatment improve the prognosis. In herds with endemic DD, ongoing control measures are necessary to maintain low prevalence.

Follow-up for digital dermatitis involves monitoring individual cows for recurrence and assessing herd-level control measures. Treated cows should be re-examined after 3-5 days to assess response to treatment. If lesions are healing (M3 stage), no further treatment may be needed. If lesions are still active, additional treatment may be required. Herd-level monitoring should include regular locomotion scoring and hoof health evaluations during routine hoof trimming. The prevalence of DD should be tracked over time to evaluate the effectiveness of control measures. Environmental hygiene should be regularly assessed, and foot bathing protocols should be adjusted as needed. Cows with chronic lesions should be identified and managed appropriately, possibly with culling if they do not respond to treatment. Nutritional management should be reviewed to ensure optimal hoof health. Biosecurity measures, such as quarantine of new animals, should be implemented to prevent introduction of the disease.

Clinical pearls: 1) Digital dermatitis lesions are typically found on the plantar aspect of the heel bulbs, and are often missed if the foot is not thoroughly cleaned. 2) The M-stage scoring system is useful for standardizing lesion assessment and monitoring treatment response. 3) Topical oxytetracycline is highly effective and inexpensive; a single application may be sufficient in some cases. 4) Foot bathing with 5% formalin or 2-5% copper sulfate is effective for herd-level control, but formalin is a carcinogen and should be used with caution. 5) Improving hygiene and reducing moisture are critical for preventing recurrence. Pitfalls: 1) Confusing DD with foot rot; foot rot requires systemic antibiotics, while DD is treated topically. 2) Neglecting to treat all affected cows, leading to a reservoir of infection. 3) Using foot baths with inadequate concentration or frequency, reducing efficacy. 4) Failing to address environmental risk factors, leading to high recurrence rates. 5) Overusing systemic antibiotics, which is unnecessary and contributes to antimicrobial resistance.

Current drug protocols for digital dermatitis are primarily topical. Topical oxytetracycline: available as a spray or solution (e.g., 100 mg/mL), applied directly to the cleaned lesion once daily for 3-5 days. Alternatively, a single application of a long-acting oxytetracycline spray may be used. Lincomycin: topical gel or solution (e.g., 10 mg/mL) applied daily for 3 days. Other topical agents include a combination of tetracycline and gentian violet, or chlortetracycline spray. For pain management, flunixin meglumine (1.1-2.2 mg/kg IV or IM) or ketoprofen (3 mg/kg IV or IM) can be given once or twice daily for 1-3 days. Systemic antibiotics are not recommended for uncomplicated DD, but if secondary infection is present, ceftiofur (2.2 mg/kg SC or IM) or oxytetracycline (10-20 mg/kg IM) may be used. Withdrawal times: For topical oxytetracycline, milk withdrawal is 0 hours if used on the skin, but meat withdrawal is 0 days if used topically; however, systemic administration requires milk withdrawal of 72 hours and meat withdrawal of 28 days for oxytetracycline. Flunixin meglumine has a milk withdrawal of 36 hours and meat withdrawal of 4 days. Always consult the label and veterinary supervision.

Evidence-based literature on digital dermatitis is extensive. Key studies have established the role of Treponema spp. in the etiology, with PCR-based identification of T. medium, T. phagedenis, and T. pedis in lesions. Clinical trials have demonstrated the efficacy of topical oxytetracycline and lincomycin, with cure rates of 70-90% for active lesions. Foot bathing with formalin or copper sulfate has been shown to reduce prevalence in herds. A meta-analysis of control measures found that a combination of foot bathing and improved hygiene is most effective. The M-stage scoring system has been validated for monitoring disease. Studies on the economic impact estimate losses of $100-200 per case due to milk loss and treatment. Recent research has focused on vaccine development, but no effective vaccine is currently available. The AABP and ECBHM have published guidelines for the control of digital dermatitis, emphasizing biosecurity, hygiene, and early treatment. Overall, the evidence supports a multifactorial approach to management.